Page 49 - Nvo News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Nvo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Capricorn Fund Managers Ltd bought a new position in shares of Novo Nordisk A/S (NYSE:NVO – Free Report) during the third quarter, HoldingsChannel.com reports. The firm bought 12,646 shares of the company’s stock, valued at approximately $1,150,000. Other institutional investors also recently made changes to their positions in the company. Ritter Daniher Financial Advisory LLC […] ....
Optimum Investment Advisors grew its holdings in shares of Novo Nordisk A/S (NYSE:NVO – Free Report) by 91.4% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 10,472 shares of the company’s stock after acquiring an additional 5,000 shares during the […] ....
Novo Nordisk A/S (NYSE:NVO – Get Free Report)‘s stock had its “overweight” rating reiterated by equities research analysts at Cantor Fitzgerald in a note issued to investors on Monday, PriceTargets.com reports. Cantor Fitzgerald also issued estimates for Novo Nordisk A/S’s FY2023 earnings at $2.65 EPS and FY2024 earnings at $3.35 EPS. A number of other […] ....
Dynamic Advisor Solutions LLC boosted its holdings in Novo Nordisk A/S (NYSE:NVO – Free Report) by 112.2% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 29,323 shares of the company’s stock after acquiring an additional 15,504 shares during the quarter. Dynamic Advisor […] ....
Agate Pass Investment Management LLC increased its stake in shares of Novo Nordisk A/S (NYSE:NVO – Free Report) by 90.3% during the 3rd quarter, Holdings Channel reports. The fund owned 13,946 shares of the company’s stock after purchasing an additional 6,618 shares during the quarter. Agate Pass Investment Management LLC’s holdings in Novo Nordisk A/S […] ....